« Previous
Next »
The Breast
Volume 19, Issue 5
, Pages
333-338
, October 2010
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
To access this article, please choose from the options below
PII: S0960-9776(10)00035-4
doi: 10.1016/j.breast.2010.01.018
© 2010 Elsevier Ltd. All rights reserved.
« Previous
Next »
The Breast
Volume 19, Issue 5
, Pages
333-338
, October 2010
